Delivery Order SPE2DB20D1100-SPE2DB25FD7H5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $45,565.02 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order, which is not set-aside, is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal healthcare systems to prevent blood clots...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency awarded a $7,980.37 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be supplied from the vendor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant...
- The Defense Logistics Agency awarded a delivery order valued at $3,011.76 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used primarily for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $15,735.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for ultimate completion by July 31, 2025, with fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely used...
- The Defense Logistics Agency awarded a $5,896.80 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This competitive award, with a firm fixed price structure and no set-aside designation, is scheduled for completion by August 18, 2025, with fulfillment to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used primarily for stroke prevention and treatment...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,257.64 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a brand-name anticoagulant...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,896.80 for 60 tablets of Eliquis 5 mg on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used to reduce stroke risk and treat blood clots, reflecting the Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order valued at $7,162.15 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment, indicating...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $10,764.56. This firm fixed-price delivery order, which is expected to be completed by July 21, 2025, represents a competitively awarded procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7H5Delivery Order
The Defense Logistics Agency awarded a $24,039.10 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement with an ultimate completion date of July 31, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment, representing a critical pharmaceutical commodity for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The parent IDC enables AmerisourceBergen to supply an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. The company's role as a prime pharmaceutical vendor reflects its established capability to meet federal procurement requirements through competitive awards and fulfill critical medical supply needs for the Defense Health Agency and other government healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.0k | 7/30/25 |